Your browser doesn't support javascript.
loading
Pre-liver transplant renal dysfunction and association with post-transplant end-stage renal disease: A single-center examination of updated UNOS recommendations.
Chauhan, Kinsuk; Azzi, Yorg; Faddoul, Geovani; Liriano-Ward, Luz; Chang, Paul; Nadkarni, Girish; Delaney, Veronica; Ames, Scott; Debnath, Neha; Singh, Nandita; Sehgal, Vinita; Di Boccardo, Graciela; Garzon, Felipe; Nair, Vinay; Kent, Rebecca; Lerner, Susan; Coca, Steven; Shapiro, Ron; Florman, Sander; Schiano, Thomas; Menon, Madhav C.
Afiliação
  • Chauhan K; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Azzi Y; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Faddoul G; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Liriano-Ward L; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Chang P; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Nadkarni G; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Delaney V; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Ames S; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Debnath N; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Singh N; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Sehgal V; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Di Boccardo G; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Garzon F; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Nair V; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Kent R; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Lerner S; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Coca S; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Shapiro R; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Florman S; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Schiano T; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Menon MC; Recanati Miller Transplant Institute, Icahn School of Medicine at Mount Sinai, New York City, New York.
Clin Transplant ; 32(12): e13428, 2018 12.
Article em En | MEDLINE | ID: mdl-30338873
ABSTRACT
Simultaneous liver-kidney allocation protocols allocate dual organs based on a sustained eGFR of 30 mL/min or less. A 2017-UNOS update includes CKD3 as dual organ candidates but only when the listing eGFR is <30 mL/min while recommending a "safety net" for prioritized kidney listing post-LT. We retrospectively reviewed adult LTs examine whether the UNOS proposal captured the LT population at highest risk for developing post-LT ESRD. Among 290 LT recipients, 67 had pre-LT CKD3, 141 had AKI, of whom 47 required dialysis (<4 weeks). During follow-up, 25 (8.62%) developed ESRD, while 70 (24.1%) died. In adjusted Cox models, CKD3 had an independent association with post-LT ESRD (adjusted HR 4.8; P = 0.001), independent of AKI. Interestingly, CKD3 with listing GFR >30 mL/min was still significantly associated with post-LT ESRD. AKI was associated with reduced post-LT survival (adjusted HR 1.9; P = 0.02), albeit only in the first-year post-LT. Severe AKI-D was associated with post-LT ESRD and mortality. The safety net would have captured only 60% of all post-LT ESRD cases in our cohort. Pre-LT CKD3 was associated with increased risk of post-LT ESRD above the recommended cutoff for listing GFR. These findings, if generalizable in larger cohorts have important implications for dual organ allocation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Transplante de Fígado / Insuficiência Renal / Doença Hepática Terminal / Rejeição de Enxerto / Sobrevivência de Enxerto / Falência Renal Crônica Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Transplante de Fígado / Insuficiência Renal / Doença Hepática Terminal / Rejeição de Enxerto / Sobrevivência de Enxerto / Falência Renal Crônica Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article